DK3429993T3 - Dopamin d3-receptor-selektive antagonister/delvise agonister; fremgangsmåde til fremstilling; og anvendelsen deraf - Google Patents
Dopamin d3-receptor-selektive antagonister/delvise agonister; fremgangsmåde til fremstilling; og anvendelsen deraf Download PDFInfo
- Publication number
- DK3429993T3 DK3429993T3 DK17711971.6T DK17711971T DK3429993T3 DK 3429993 T3 DK3429993 T3 DK 3429993T3 DK 17711971 T DK17711971 T DK 17711971T DK 3429993 T3 DK3429993 T3 DK 3429993T3
- Authority
- DK
- Denmark
- Prior art keywords
- dopamin
- manufacturing
- application
- partial agonists
- selective antagonists
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 1
- 229960003638 dopamine Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000004031 partial agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307600P | 2016-03-14 | 2016-03-14 | |
| PCT/US2017/021328 WO2017160552A1 (en) | 2016-03-14 | 2017-03-08 | Dopamine d3 receptor selective antagonists/partial agonists; method of making; and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3429993T3 true DK3429993T3 (da) | 2021-08-09 |
Family
ID=58358971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17711971.6T DK3429993T3 (da) | 2016-03-14 | 2017-03-08 | Dopamin d3-receptor-selektive antagonister/delvise agonister; fremgangsmåde til fremstilling; og anvendelsen deraf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12162861B2 (da) |
| EP (2) | EP3848351B1 (da) |
| AU (1) | AU2017233716B2 (da) |
| CA (1) | CA3017342A1 (da) |
| DK (1) | DK3429993T3 (da) |
| ES (1) | ES2881267T3 (da) |
| HR (1) | HRP20211182T1 (da) |
| HU (1) | HUE055634T2 (da) |
| PL (1) | PL3429993T3 (da) |
| PT (1) | PT3429993T (da) |
| RS (1) | RS62156B1 (da) |
| SI (1) | SI3429993T1 (da) |
| WO (1) | WO2017160552A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3849963A1 (en) | 2018-09-11 | 2021-07-21 | The United States of America, as Represented By the Secretary, Department of Health and Human Services | Dopamine d3 receptor selective antagonists/partial agonists and uses thereof |
| EP4380921B1 (en) * | 2021-08-03 | 2026-01-28 | The United States of America, as represented by The Secretary, Department of Health and Human Services | D3 dopamine receptor-selective negative allosteric modulators |
| CN114409621B (zh) * | 2022-02-09 | 2023-09-08 | 江苏省原子医学研究所 | 一种靶向多巴胺d3受体的诊疗药物及其应用 |
| EP4499619A1 (en) * | 2022-03-30 | 2025-02-05 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Synthesis of dopamine d3 receptor selective antagonists/partial agonists |
| WO2025006982A1 (en) * | 2023-06-30 | 2025-01-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Potent and selective dopamine d3 receptor antagonists |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5710274A (en) | 1996-02-28 | 1998-01-20 | Neurogen Corporation | N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
| US5763609A (en) | 1996-03-21 | 1998-06-09 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands |
| US5892041A (en) | 1996-08-12 | 1999-04-06 | Neurogen Corporation | Fused indolecarboxamides: dopamine receptor subtype specific ligands |
| HUP0103987A3 (en) * | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
| ATE354367T1 (de) | 2002-07-04 | 2007-03-15 | Sanol Arznei Schwarz Gmbh | Heteroarencarboxamide zur verwendung als dopamin- d3 liganden zur behandlung von zns-erkrankungen |
| WO2004024878A2 (en) | 2002-09-14 | 2004-03-25 | Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services | Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| JP2008508337A (ja) | 2004-08-02 | 2008-03-21 | シュバルツ ファルマ アクチェンゲゼルシャフト | インドリジンカルボキサミド並びにそのアザ及びジアザ誘導体 |
| DE102004054634A1 (de) | 2004-11-12 | 2006-05-18 | Schwarz Pharma Ag | Azaindolcarboxamide |
| CA2593266A1 (en) | 2005-01-03 | 2006-07-13 | Universita Degli Studi Di Siena | Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| FR2903986A1 (fr) | 2006-07-21 | 2008-01-25 | Pierre Fabre Medicament Sa | Nouveaux derives chromenes ou thiochromenes carboxamides, leur procede de preparation et leurs applications en therapeutique |
| WO2008153573A1 (en) | 2007-06-15 | 2008-12-18 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use |
| WO2014059265A1 (en) * | 2012-10-11 | 2014-04-17 | Southern Research Institute | Urea and amide derivatives of aminoalkylpiperazines and use thereof |
| EP3849963A1 (en) | 2018-09-11 | 2021-07-21 | The United States of America, as Represented By the Secretary, Department of Health and Human Services | Dopamine d3 receptor selective antagonists/partial agonists and uses thereof |
-
2017
- 2017-03-08 SI SI201730863T patent/SI3429993T1/sl unknown
- 2017-03-08 PT PT177119716T patent/PT3429993T/pt unknown
- 2017-03-08 PL PL17711971T patent/PL3429993T3/pl unknown
- 2017-03-08 AU AU2017233716A patent/AU2017233716B2/en active Active
- 2017-03-08 WO PCT/US2017/021328 patent/WO2017160552A1/en not_active Ceased
- 2017-03-08 EP EP21158632.6A patent/EP3848351B1/en active Active
- 2017-03-08 DK DK17711971.6T patent/DK3429993T3/da active
- 2017-03-08 HU HUE17711971A patent/HUE055634T2/hu unknown
- 2017-03-08 CA CA3017342A patent/CA3017342A1/en active Pending
- 2017-03-08 HR HRP20211182TT patent/HRP20211182T1/hr unknown
- 2017-03-08 EP EP17711971.6A patent/EP3429993B1/en active Active
- 2017-03-08 RS RS20210938A patent/RS62156B1/sr unknown
- 2017-03-08 ES ES17711971T patent/ES2881267T3/es active Active
-
2022
- 2022-03-03 US US17/685,709 patent/US12162861B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017233716B2 (en) | 2020-10-29 |
| WO2017160552A1 (en) | 2017-09-21 |
| SI3429993T1 (sl) | 2021-09-30 |
| PL3429993T3 (pl) | 2021-11-15 |
| RS62156B1 (sr) | 2021-08-31 |
| EP3848351B1 (en) | 2025-01-15 |
| HRP20211182T1 (hr) | 2021-10-15 |
| PT3429993T (pt) | 2021-07-19 |
| EP3429993B1 (en) | 2021-05-26 |
| EP3429993A1 (en) | 2019-01-23 |
| ES2881267T3 (es) | 2021-11-29 |
| US20220185798A1 (en) | 2022-06-16 |
| US12162861B2 (en) | 2024-12-10 |
| HUE055634T2 (hu) | 2021-12-28 |
| EP3848351A1 (en) | 2021-07-14 |
| AU2017233716A1 (en) | 2018-10-04 |
| CA3017342A1 (en) | 2017-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3524603T3 (da) | Fgfr4-hæmmer, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3555064T3 (da) | GLP-1 receptoragonister og anvendelser deraf | |
| DK3596053T3 (da) | Farnesoid-x-receptoragonister og anvendelser deraf | |
| DK3374163T3 (da) | Additivfremstillingsanordning, system og fremgangsmåde | |
| EP3693912A4 (en) | PREDICTION PROCESS AND TERMINAL AND SERVER | |
| DK3350165T3 (da) | Farnesoid-X-receptoragonister og anvendelser deraf | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3134149T3 (da) | Mikrokanyler og fremgangsmåder til fremstilling deraf | |
| DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
| DK3105335T3 (da) | Kimære antigenreceptorer og fremgangsmåder til fremstilling heraf | |
| BR112016027464A2 (pt) | aparelho de rede, e método de rede | |
| DK3398022T3 (da) | Systemer og fremgangsmåder til tilpasning af uav-bane | |
| EP3681083C0 (en) | METHOD, APPARATUS AND DEVICE FOR RESOURCE PLANNING | |
| DK3212218T3 (da) | GIP-agonistforbindelser og fremgangsmåder | |
| DK3113797T3 (da) | Antistoffer, anvendelser og fremgangsmåder | |
| BR112015003089A2 (pt) | método e aparelho de conexão de rede | |
| DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
| DK3342571T3 (da) | Blandeindretning og blandefremgangsmåde | |
| DK3368613T3 (da) | Matteringsmiddel og fremgangsmåde til fremstilling deraf | |
| DK3359563T3 (da) | Antigenreceptorer og anvendelser deraf | |
| EP3464656C0 (en) | MANUFACTURING APPARATUS AND METHOD | |
| DK3265123T5 (da) | Antistoffer, anvendelser og fremgangsmåder | |
| DK3685007T3 (da) | Systemer og metoder for serviceværktøjer til borehuller | |
| EP3534182A4 (en) | Positioning augmentation device, positioning augmentation method, and positioning augmentation program | |
| EP3664570A4 (en) | SESSION ESTABLISHMENT PROCESS AND APPARATUS |